Accendra Health (NYSE:ACH) Downgraded by Robert W. Baird to Hold

Accendra Health (NYSE:ACH) was downgraded by investment analysts at Robert W. Baird from a “strong-buy” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.

A number of other equities research analysts have also weighed in on the stock. UBS Group raised their price target on shares of Accendra Health from $3.00 to $4.50 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Zacks Research upgraded shares of Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. Citigroup cut shares of Accendra Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $4.50 to $1.50 in a research report on Monday. Finally, Weiss Ratings lowered Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, August 6th. Four equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Accendra Health currently has a consensus rating of “Reduce” and an average price target of $2.50.

Accendra Health Stock Performance

NYSE ACH opened at $1.24 on Tuesday. The stock has a market cap of $94.96 million, a PE ratio of -0.32, a PEG ratio of 2.16 and a beta of 1.58. Accendra Health has a fifty-two week low of $1.20 and a fifty-two week high of $5.85. The business has a 50 day moving average of $3.13.

Accendra Health (NYSE:ACH) last issued its quarterly earnings data on Monday, August 10th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.06). The firm had revenue of $613.23 million during the quarter. Accendra Health had a negative net margin of 11.41% and a negative return on equity of 4.24%. Equities analysts anticipate that Accendra Health will post 0.31 EPS for the current fiscal year.

Institutional Trading of Accendra Health

Several institutional investors have recently added to or reduced their stakes in the stock. Walleye Capital LLC acquired a new stake in Accendra Health in the first quarter valued at $27,000. Hsbc Holdings PLC acquired a new position in Accendra Health during the 1st quarter worth $34,000. Abel Hall LLC acquired a new position in Accendra Health during the 1st quarter worth $44,000. Keybank National Association OH bought a new stake in shares of Accendra Health in the 1st quarter worth about $46,000. Finally, The Manufacturers Life Insurance Company bought a new stake in shares of Accendra Health in the 1st quarter worth about $50,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.